GPR65/TDAG8 modulators (Omeros)

N/A

Report date: 2025/03/20 14:53:29
NME

Base Information

Drug NameGPR65/TDAG8 modulators (Omeros)
Drug Alias NameGPR65 modulators (Omeros)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionG-protein coupled receptor 65 modulators
TargetsG-protein coupled receptor 65
Therapy Area/IndicationsInflammationOvarian NeoplasmsCarcinoma, Renal Cell +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOmeros Corp
China Registration ClassN/A

Develop Information

Active CompaniesOmeros Corp
Inactive CompaniesN/A
Active IndicationsInflammationOvarian NeoplasmsCarcinoma, Renal Cell
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A